These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 11799104

  • 1. Kinetic characterization of compound I formation in the thermostable cytochrome P450 CYP119.
    Kellner DG, Hung SC, Weiss KE, Sligar SG.
    J Biol Chem; 2002 Mar 22; 277(12):9641-4. PubMed ID: 11799104
    [Abstract] [Full Text] [Related]

  • 2. Kinetics and activation parameters for oxidations of styrene by Compounds I from the cytochrome P450(BM-3) (CYP102A1) heme domain and from CYP119.
    Yuan X, Wang Q, Horner JH, Sheng X, Newcomb M.
    Biochemistry; 2009 Sep 29; 48(38):9140-6. PubMed ID: 19708688
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel intermediate in the reaction of seleno CYP119 with m-chloroperbenzoic acid.
    Sivaramakrishnan S, Ouellet H, Du J, McLean KJ, Medzihradszky KF, Dawson JH, Munro AW, Ortiz de Montellano PR.
    Biochemistry; 2011 Apr 12; 50(14):3014-24. PubMed ID: 21381758
    [Abstract] [Full Text] [Related]

  • 8. Crystallization and preliminary X-ray diffraction analysis of a cytochrome P450 (CYP119) from Sulfolobus solfataricus.
    Park SY, Yamane K, Adachi S, Shiro Y, Weiss KE, Sligar SG.
    Acta Crystallogr D Biol Crystallogr; 2000 Sep 12; 56(Pt 9):1173-5. PubMed ID: 10957637
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protein control of the formation and decomposition of the CYP119 and CYP101 aryl-iron complexes.
    Tschirret-Guth RA, Koo LS, Ortiz de Montellano PR.
    J Biol Inorg Chem; 2000 Apr 12; 5(2):204-12. PubMed ID: 10819465
    [Abstract] [Full Text] [Related]

  • 11. Spectroscopic characterization of cytochrome P450 Compound I.
    Jung C, de Vries S, Schünemann V.
    Arch Biochem Biophys; 2011 Mar 01; 507(1):44-55. PubMed ID: 21195047
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a cytochrome P450 from the acidothermophilic archaea Sulfolobus solfataricus.
    McLean MA, Maves SA, Weiss KE, Krepich S, Sligar SG.
    Biochem Biophys Res Commun; 1998 Nov 09; 252(1):166-72. PubMed ID: 9813164
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cytochrome P450: the active oxidant and its spectrum.
    Rittle J, Younker JM, Green MT.
    Inorg Chem; 2010 Apr 19; 49(8):3610-7. PubMed ID: 20380463
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Sulfolobus solfataricus electron donor partners of thermophilic CYP119: an unusual non-NAD(P)H-dependent cytochrome P450 system.
    Puchkaev AV, Ortiz de Montellano PR.
    Arch Biochem Biophys; 2005 Feb 01; 434(1):169-77. PubMed ID: 15629120
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mechanistic insight into formation of oxo-iron(IV) porphyrin pi-cation radicals from enzyme mimics of cytochrome P450 in organic solvents.
    Hessenauer-Ilicheva N, Franke A, Meyer D, Woggon WD, van Eldik R.
    Chemistry; 2009 Feb 01; 15(12):2941-59. PubMed ID: 19185039
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.